GAROFALO ELIZABETH A. Insider Trades

Insider Trading History

Track insider trading activity for GAROFALO ELIZABETH A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $348k 16,004 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$548k 25,315 shares
$21.66
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $727k 33,489 shares
Last Trade
May 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$176k 8,107 shares
$21.66
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$176k 8,107 shares
$21.66
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $551k 25,382 shares
Last Trade
Sep 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$41.6k 1,600 shares
$25.98
$21.72
Alector
Alector ALEC
Director
Holding Value $163k 89,950 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.4k 9,450 shares
$1.63
$1.81
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $901k 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$52.99
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $586k 26,982 shares
Last Trade
May 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 9,387 shares
$22.29
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 9,387 shares
$22.29
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $300k 13,793 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 13,793 shares
$22.29
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $382k 17,595 shares
Last Trade
Mar 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$89.7k 4,919 shares
$18.23
$21.72
Alector
Alector ALEC
Director
Holding Value $111k 61,250 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 35,000 shares
$4.70
$1.81
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $824k 15,542 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$593k 15,542 shares
$38.16
$52.99
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $347k 15,959 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 15,959 shares
$14.62
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$97.3k 6,652 shares
$14.62
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $489k 22,514 shares
Last Trade
May 29, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$97.3k 6,652 shares
$14.62
$21.72
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
Mar 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$95.6k 2,092 shares
$45.69
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $111k 2,092 shares
Last Trade
Mar 08, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$65k 1,408 shares
$46.16
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $185k 3,500 shares
Last Trade
Mar 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$162k 3,500 shares
$46.24
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $874k 16,500 shares
Last Trade
Mar 08, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$162k 3,500 shares
$46.24
$52.99
Alector
Alector ALEC
Director
Holding Value $47.5k 26,250 shares
Last Trade
Dec 05, 2023 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$51.9k 9,459 shares
$5.49
$1.81

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up